LEO Pharma is a global organisation with a rich history and heritage in developing innovative research and holistic programmes. We are passionate about meeting unmet medical needs globally and are focused on improving the lives of people that live with dermatological (skin) and thrombotic (blood clot) conditions. We are owned in full by the LEO Foundation, which means that we are completely independent and have a stable environment that encourages long-term research and development and programmes.
At LEO Pharma UK/IE, we see the people who we are committed to helping as individuals that all have different needs. We drive forward our commitment to put patients at the core of all we do, with our patient focused approach that we refer to as Helping SARAH. We do this through our unrivalled patient engagement, disease awareness initiatives and pioneering research and development, all of which aims not only to treat conditions but also helps people with these conditions to live well. In the case of thrombosis we ultimately aim to prevent conditions from presenting in the first place.